Hyperphosphatemia is a common complication of chronic kidney disease in cats. Phosphate binders are a key tool for controlling blood phosphorus levels.





| Item | Calciite | Aluminum Hydroxide | Serestil |
|---|---|---|---|
| Phosphorus Binding Capacity | High | Very high | Moderate |
| Side Effect Risk | Moderate | High | Low |
| Dosage Form | Powder/tablet | Powder/tablet | Chewable form |
| Suitability for Long-term Use | Moderate | Low | High |
| Recommended For | General cats | Severe hyperphosphatemia | Cats requiring calcium restriction |
Choose according to your veterinarian's diagnosis and prescription. If abnormal symptoms appear during use, an immediate hospital visit is needed.
Caution: Risk of Aluminum Accumulation with Long-Term Use
Aluminum-based phosphate binders can cause neurological symptoms such as encephalopathy due to aluminum toxicity with long-term use. This is especially concerning in cats with severely impaired kidney function. Regular blood tests, a complete blood count (CBC) to check for microcytic anemia, and ongoing veterinary monitoring are essential.


A veterinarian who majored in veterinary medicine at Khon Kaen University, Thailand, and completed the IVSA program at North Carolina State University in the United States. Drawing on clinical experience at animal hospitals, he works in the pet healthcare field and is dedicated to building a digital care environment that connects pet parents with veterinarians.
Share
[1] The Cat, Clinical Medicine and Management, 2nd Edition. Elsevier, 2020.
[2] Plumb's Veterinary Drug Handbook, 9th Edition. Wiley-Blackwell, 2021.
[3] Feline Chronic Kidney Disease: A Practical Guide for Veterinarians. Veterinary Learning Systems, 2019.